AptarGroup Inc (ATR)

Official site

HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NYSE

$142.51

-1.53 (-1.06%)

Market Cap: $9.13B

Last updated: Nov 06, 2026 at 4:10 PM ET

Earnings

Performance (10Y)

Beat Rate

93%(37/40)

Avg Surprise

+6.20%

Streak

21 Q

Upcoming Estimates

Period ending Dec 31, 2026

EPS Consensus$1.51

Range$1.41 - $1.57

7 analysts

Revenue Consensus

$1.0B

Range$1.0B - $1.1B

2 analysts

Period ending Mar 31, 2027

EPS Consensus$1.34

Range$1.30 - $1.39

4 analysts

EPS RevisionsNo revisions (7d)

30d

EPS Estimate DriftChange to current

90d ago$1.36-1.5%

60d ago$1.39-3.4%

30d ago$1.39-3.4%

7d ago$1.36-1.0%

Current$1.34

Revenue Consensus

$1.0B

Range$986M - $1.0B

4 analysts

Last 12 of 40 reported quarters and 2 upcoming estimates

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Mar 31, 2027Mar 27EST	-	$1.34	$1.30 - $1.39	-	-	4	0 1 30d	-
Dec 31, 2026Dec 26EST	-	$1.51	$1.41 - $1.57	-	-	7	-	-
Sep 30, 2026Sep 26 Reported Oct 29, 2026Reported Oct 29	$1.52	$1.46	$1.45 - $1.49	+4.11%	Beat	8	0 1 30d	-6.2%
Jun 30, 2026Jun 26 Reported Jul 30, 2026Reported Jul 30	$1.42	$1.34	$1.33 - $1.38	+5.97%	Beat	7	3 3 30d	-14.5%
Mar 31, 2026Mar 26 Reported Apr 30, 2026Reported Apr 30	$1.19	$1.15	$1.14 - $1.18	+3.48%	Beat	7	0 3 30d	-0.8%
Dec 31, 2025Dec 25 Reported Feb 5, 2026Reported Feb 5	$1.25	$1.23	$1.20 - $1.27	+1.63%	Beat	7	0 2 30d	-17.8%
Sep 30, 2025Sep 25 Reported Oct 30, 2025Reported Oct 30	$1.62	$1.57	$1.54 - $1.59	+3.18%	Beat	6	2 0 30d	+8.7%
Jun 30, 2025Jun 25 Reported Jul 31, 2025Reported Jul 31	$1.66	$1.59	$1.57 - $1.60	+4.40%	Beat	5	0 2 30d	+21.2%
Mar 31, 2025Mar 25 Reported May 1, 2025Reported May 1	$1.20	$1.16	$1.13 - $1.19	+3.45%	Beat	6	1 1 30d	-4.8%
Dec 31, 2024Dec 24 Reported Feb 6, 2025Reported Feb 6	$1.52	$1.26	$1.22 - $1.28	+20.63%	Beat	6	0 3 30d	+25.6%
Sep 30, 2024Sep 24 Reported Oct 24, 2024Reported Oct 24	$1.49	$1.42	$1.41 - $1.43	+4.93%	Beat	5	1 0 30d	+7.2%
Jun 30, 2024Jun 24 Reported Jul 25, 2024Reported Jul 25	$1.37	$1.35	$1.34 - $1.39	+1.48%	Beat	5	No revisions (30d)	+11.4%
Mar 31, 2024Mar 24 Reported Apr 25, 2024Reported Apr 25	$1.26	$1.15	$1.11 - $1.18	+9.57%	Beat	5	No revisions (30d)	+32.6%
Dec 31, 2023Dec 23 Reported Feb 8, 2024Reported Feb 8	$1.21	$1.12	$1.10 - $1.13	+8.04%	Beat	5	No revisions (30d)	+31.5%

Dividends

Next ex-dividend: Nov 12, 2026

Dividend Metrics

Forward Yield1.35%

Forward Annual Dividend$1.92

Payout Ratio15.95%

FrequencyQuarterly

Pay MonthsFeb, May, Aug, Nov, Dec

Growth

3Y CAGR+6.38%

5Y CAGR+4.91%

ATR dividend history and ex-dividend dates Run ATR in the free DRIP calculator

Key Metrics

Valuation
P/E Ratio	26.49	EV/EBITDA	13.21x
Price/FCF	30.72x	FCF Yield	3.26%
Profitability
Profit Margin	6.70%	Operating Margin	13.80%
ROE	9.79%	ROIC	8.65%
Financial Health
Debt/Equity	0.54x	Interest Coverage	7.14x
Current Ratio	1.50x	Quick Ratio	1.03x
Trading Statistics
Beta	0.32	Avg Volume	544.66K
52-Week High	$148.63	52-Week Low	$110.56

Technical Indicators Dashboard

Moving Averages

SMA 10$136.82

SMA 20$130.30

SMA 50$126.80

SMA 200$127.01

EMA 10$138.23

EMA 20$133.30

EMA 50$129.21

EMA 200$128.07

MACD

Line: 5.21Signal: 3.24Hist: 1.97

ADX

ADX: 40.4+DI: 37.1-DI: 10.6

Aroon & PSAR

Aroon Up96.0

Aroon Down28.0

PSAR$137.97

Bollinger Bands

Upper Band$148.30

Lower Band$112.31

%B Position2762%(Upper)

Band Width0.84

RSI (14-Day)

Overbought

70.0

Momentum Oscillators

Stoch %K85.2

Stoch %D90.7

Williams %R-24.9

ROC (10d)12.6%

Momentum15.96

CCI (20d)104.2

MFI (14d)74.6

Volatility Measures

ATR (14d)$3.75(2.6%)

StdDev (20d)9.00

Hist Vol32.1%(Moderate)

Volume Flow

VWAP$141.62

OBV-2.1M

AD Line-81.2M

CMF (20d)0.149

Volume Metrics

Avg Vol (20d)541.9K

Vol Ratio0.9x

VWMA (20d)$131.96

Pivot Points

R3$154.38

R2$151.51

R1$147.77

Pivot Point$144.90

S1$141.16

S2$138.29

S3$134.55

Advanced Oscillators

TSI43.97

Ultimate Osc65.9

KST103.38

Financial Data

Quarter	Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023
Total Revenue	$1.02B	$1.03B	$982.87M	$962.74M	$961.13M	$966.01M	$887.30M	$848.09M	$909.29M	$910.06M	$915.45M	$838.48M
Cost of Revenue	$646.20M	$660.99M	$630.96M	$624.51M	$598.05M	$598.99M	$550.89M	$518.67M	$558.51M	$567.44M	$582.76M	$526.23M
Gross Profit	$372.92M	$365.52M	$351.91M	$338.22M	$363.08M	$367.01M	$336.41M	$329.41M	$350.78M	$342.62M	$332.69M	$312.25M

Operating Expenses	$237.92M	$238.79M	$244.41M	$231.95M	$226.16M	$222.62M	$222.97M	$209.31M	$212.48M	$216.61M	$220.61M	$228.05M
R&D	$160.16M	$157.74M	$167.60M	$151.32M	$148.76M	$151.14M	$155.28M	$138.51M	$141.60M	$149.33M	$152.78M	$138.29M
SG&A	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Operating Income	$135.01M	$126.72M	$107.50M	$106.27M	$136.92M	$144.39M	$113.45M	$120.11M	$138.30M	$126.01M	$112.08M	$84.20M

Interest Income	$-55,995,000	$5.13M	$3.27M	$4.50M	$3.99M	$6.29M	$3.80M	$3.55M	$3.99M	$3.09M	$3.27M	$2.39M
Interest Expense	$15.79M	$16.00M	$16.94M	$17.00M	$13.53M	$10.85M	$11.35M	$11.37M	$12.29M	$10.06M	$10.18M	$10.52M
Income Before Tax	$60.33M	$115.05M	$93.77M	$91.52M	$154.13M	$139.71M	$106.02M	$116.07M	$131.13M	$118.25M	$104.32M	$80.63M
Income Tax Expense	$27.51M	$27.04M	$21.00M	$17.25M	$26.30M	$27.98M	$27.35M	$15.21M	$31.21M	$27.79M	$21.39M	$18.38M

Net Income	$32.82M	$88.01M	$72.77M	$74.27M	$127.83M	$111.73M	$78.66M	$100.86M	$99.92M	$90.46M	$82.93M	$62.24M

EBITDA	$207.66M	$205.56M	$183.17M	$180.60M	$238.91M	$214.18M	$179.21M	$191.34M	$206.45M	$190.18M	$175.57M	$153.13M
EBIT	$132.12M	$125.92M	$107.44M	$104.02M	$163.67M	$144.27M	$113.56M	$123.89M	$139.43M	$125.22M	$111.22M	$88.75M

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about ATR

Government Contracts

Gov Obligations (TTM)

$650036

Gov Obligations / Revenue

0.0%

Obligations YoY

-89.1%

Active Awards

New Awards (TTM)

Avg Remaining Term

13.5 mo

Top agency: Department of Health and Human Services at 100.0% of trailing twelve month obligations across 1 agencies

Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

News

Form 4 AptarGroup Inc: George L. Fotiades (Director) For: 5 November By Investing.com

This article reports on a Form 4 filing for AptarGroup Inc, detailing a transaction by Director George L. Fotiades on November 5th. Form 4 filings are used to disclose changes in beneficial ownership of securities by...

Investing.com India•Nov 6, 2026 9:28 AM ET11/6/26•Neutral

AptarGroup Inc stock hits 52-week high at 146.92 USD By Investing.com

AptarGroup Inc. (ATR) stock recently hit a 52-week high of $146.92, driven by strong market demand and strategic business initiatives...

Investing.com UK•Nov 4, 2026 11:40 AM ET11/4/26•Bullish

$274K in AptarGroup (ATR) shares is slated for sale by officer Marc Prieur.

AptarGroup officer Marc Prieur plans to sell 2,000 common shares of the company, valued at $274,000, around November 2, 2026...

Stock Titan•Nov 2, 2026 7:41 AM ET11/2/26•Neutral

AptarGroup 3Q 2026: Revenue $1.02B, Net income $32.6M, EPS $0.51— 10-Q Summary

AptarGroup reported its third-quarter 2026 financial results, with revenue increasing 6% year-over-year to $1.02 billion. Despite the revenue growth...

TradingView•Oct 31, 2026 12:42 AM ET10/31/26•Somewhat-Bearish

Aptar Earnings: Headline Result Masks Excellent Underlying Margin Improvement in Pharma

Aptar's core sales increased by 5% year-on-year, though adjusted EBITDA margin saw a 190 basis point decline to 21.3%. Despite overall margin compression...

Morningstar•Oct 30, 2026 9:41 PM ET10/30/26•Somewhat-Bullish

ATR Valuation and Fair Value

P/E: 26.5x
Forward P/E: 24.2x
EV/EBITDA: 13.2x
P/FCF: 30.7x
PEG: 3.2x
P/B: 3.5x

See GNG's fair value

ATR Profitability: Margins, ROIC and FCF

Gross margin: 35.8%
Operating margin: 13.8%
Net margin: 6.7%
ROIC: 8.6%
ROE: 9.8%
FCF margin: 7.4%
FCF yield: 3.3%

ATR Competitors

Company	Ticker
Spyre Therapeutics Inc.	SYRE
HealthEquity Inc	HQY
Krystal Biotech Inc	KRYS
TG Therapeutics Inc	TGTX
Protagonist Therapeutics Inc	PTGX
Bruker Corporation	BRKR
Madrigal Pharmaceuticals Inc	MDGL
Immunitybio Inc	IBRX

Sector: Healthcare

ATR Analyst Ratings

Consensus: Buy
Analysts: 9
Strong Buy: 2
Buy: 5
Hold: 2
Sell: 0
Strong Sell: 0

ATR Bull Case vs Bear Case

Bull case

ATR beat EPS estimates in 100.0% of its last 8 reported quarters.
77.8% of ATR's analyst ratings are Buy or Strong Buy.

ATR Earnings: Beat Rate and Next Report

Beat rate: 8 of 8 quarters (100.0%)
Average surprise: 5.9%
EPS estimate (fiscal period ending Dec 31, 2026): $1.51

ATR Dividend

Forward yield: 1.3%
Payout ratio: 16.0%
3Y DPS growth: 6.4%
5Y DPS growth: 4.9%
Pay months: Feb, May, Aug, Nov, Dec

ATR dividend history

ATR Earnings Date

ATR reports Feb 3, 2027, after the close. The date is estimated.

ATR Earnings Call

The latest ATR earnings call transcript on file is labeled 2026Q3.

Read the 2026Q3 transcript

ATR ETF Holders

GNG tracks 23 ETFs that hold ATR. The largest weights:

SMOT, 0.67% of the fund
Vanguard Materials Index Fund ETF Shares (VAW), 0.54% of the fund
State Street SPDR S&P Dividend ETF (SDY), 0.32% of the fund
S&P MidCap 400 ETF (MDY), 0.23% of the fund
Vanguard Morningstar Small-Cap Value ETF (VBR), 0.18% of the fund

Open the ETF Stock Exposure tool for ATR

See insider activity

Frequently Asked Questions About ATR

When is ATR's next ex-dividend date?

ATR's next ex-dividend date is Nov 12, 2026, for a declared dividend of $0.5 per share (record date Nov 12, 2026, payable Dec 3, 2026).

When does ATR report earnings?

AptarGroup Inc (ATR) is expected to report earnings on Feb 3, 2027.

What is ATR's current dividend yield?

AptarGroup Inc (ATR) has a forward dividend yield of 1.35%.

Does ATR pay dividends?

Yes, AptarGroup Inc pays dividends with a forward dividend yield of 1.35%.

What is ATR's P/E ratio?

AptarGroup Inc has a price-to-earnings (P/E) ratio of 26.49.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In